Humanin Dosage Guide
Complete guide to Humanin dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
100 mcg – 500 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
4–8 weeks
Reconstitution
Vial Size
1 mg
BAC Water
1.0 ml
Concentration
1,000 mcg/ml
Detailed Dosage Information
Research protocols vary widely.
Studies have used doses from micrograms to milligrams depending on the analog and route.
HNG (S14G-Humanin) is a more potent analog.
Administration Method
Subcutaneous or intraperitoneal injection in research. Various analogs exist with different potencies and stabilities.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 1 mg/ml
Volume to inject: 0.300 ml
Syringe units: 30.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Humanin defaults. Adjust values as needed.
Side Effects to Monitor
Limited human data. Generally well-tolerated in animal studies. May affect glucose metabolism.
Safety Considerations & Risks
Mostly studied in animal models. Long-term human safety not established. May interact with growth factor pathways.